Zastosowanie bevacizumabu u pacjentów z zaawansowaną wysiękową postacią AMD
Bevacizumab Administration in Patients with Advanced Wet AMD
Małgorzata Wojnar, Agnieszka Bartczak, Zofia Mariak
Klinika Okulistyki Uniwersytetu Medycznego w Białymstoku
Kierownik: prof. dr hab. n. med. Zofia Mariak
Summary: Aim of the study: Evaluation of the efficacy of intravitreal bevacizumab administration in patients with advanced forms of wet AMD.
Material and Methods: 18 patients were included into the study (11 women, 7 men, aged .... ) with the advanced form of wet AMD. Bevacizumab was administered in monthly injections for 3 months.
Results: The visual acuity improvement was observed in 2 cases (13.3% of patients), while VA stabilization was observed in 15 patients (83.3%). Visual acuity was reduced only in 1 case. Bevacizumab may be the alternative treatment option in patients with advanced form of wet AMD to preserve and stabilize vision.
Słowa kluczowe: zwyrodnienie plamki związane z wiekiem (AMD), bevacizumab, CNV.
Keywords: age-related macular degeneration (AMD), bevacizumab, CNV.